2. Academic Validation
  3. Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections

Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections

  • ACS Med Chem Lett. 2013 May 8;4(7):585-9. doi: 10.1021/ml400095m.
Angus M MacLeod 1,  Dale R Mitchell 1,  Nicholas J Palmer 1,  Hervé Van de Poël 1,  Katja Conrath 2,  Martin Andrews 2,  Pieter Leyssen 3,  Johan Neyts 3
Affiliations

Affiliations

  • 1 Medicinal Chemistry Department, BioFocus , Chesterford Research Park, Cambridge, CB10 1XL, U.K.
  • 2 Galapagos NV , Generaal de Wittelaan, 2800 Mechelen, Belgium.
  • 3 Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven , Leuven, Belgium.
PMID: 24900715 DOI: 10.1021/ml400095m
Abstract

Rhinovirus (genus Enterovirus) infections are responsible for many of the severe exacerbations of asthma and chronic obstructive pulmonary disease. Other members of the genus can cause life-threatening acute neurological infections. There is currently no Antiviral drug approved for the treatment of such infections. We have identified a series of potent, broad-spectrum Antiviral compounds that inhibit the replication of the human rhinovirus, Coxsackie virus, poliovirus, and enterovirus-71. The mechanism of action of the compounds has been established as inhibition of a lipid kinase, PI4KIIIβ. Inhibition of hepatitis C replication in a replicon assay correlated with Enterovirus inhibition.

Keywords

HCV; PI4KIIIβ; antiviral; enterovirus; inhibitor.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z